1. Home
  2. AMS vs BNGO Comparison

AMS vs BNGO Comparison

Compare AMS & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Shared Hospital Services

AMS

American Shared Hospital Services

HOLD

Current Price

$1.51

Market Cap

11.1M

Sector

Health Care

ML Signal

HOLD

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.09

Market Cap

12.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMS
BNGO
Founded
1980
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
11.1M
12.5M
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
AMS
BNGO
Price
$1.51
$1.09
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
24.7K
97.1K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
94.50
EPS
N/A
N/A
Revenue
$19,714,000.00
$12,000,735.00
Revenue This Year
$6.93
$14.99
Revenue Next Year
N/A
$34.73
P/E Ratio
N/A
N/A
Revenue Growth
0.81
26.26
52 Week Low
$1.25
$1.06
52 Week High
$3.11
$5.50

Technical Indicators

Market Signals
Indicator
AMS
BNGO
Relative Strength Index (RSI) 53.96 38.81
Support Level $1.37 $1.08
Resistance Level $1.75 $1.19
Average True Range (ATR) 0.07 0.03
MACD 0.01 -0.01
Stochastic Oscillator 61.54 14.29

Price Performance

Historical Comparison
AMS
BNGO

About AMS American Shared Hospital Services

American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. Company operates in two segments, the medical equipment leasing segment where a contract exists between the hospital and the Company and the direct patient services segment, where a contract exists between the Company facilities and the individual treated at the facility. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates it's key revenue from the domestic market.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Share on Social Networks: